Medical Intelligence Quiz
Challenge Yourself, Build Your Knowledge
HSC donors & health-related quality of life
Question 1 of 5
Topics
Fast Facts Friday
Fast Facts Friday
Quiz | |
---|---|
Fast Facts Friday, July 14, 2023 | Take Quiz |
Fast Facts Friday, July 7, 2023 | Take Quiz |
Fast Facts Friday, June 30, 2023 | Take Quiz |
Fast Facts Friday, June 23, 2023 | Take Quiz |
Fast Facts Friday, June 16, 2023 | Take Quiz |
Fast Facts Friday, June 9, 2023 | Take Quiz |
Fast Facts Friday, June 2, 2023 | Take Quiz |
Fast Facts Friday, May 26, 2023 | Take Quiz |
Fast Facts Friday, May 19, 2023 | Take Quiz |
Fast Facts Friday, May 12, 2023 | Take Quiz |
Fast Facts Friday, May 5, 2023 | Take Quiz |
Fast Facts Friday, April 28, 2023 | Take Quiz |
Fast Facts Friday, April 21, 2023 | Take Quiz |
Fast Facts Friday, April 14, 2023 | Take Quiz |
Fast Facts Friday, April 7, 2023 | Take Quiz |
Fast Facts Friday, March 31, 2023 | Take Quiz |
Fast Facts Friday, March 24, 2023 | Take Quiz |
Fast Facts Friday, March 17, 2023 | Take Quiz |
Fast Facts Friday, March 10, 2023 | Take Quiz |
Fast Facts Friday, March 3, 2023 | Take Quiz |
Fast Facts Friday, February 24, 2023 | Take Quiz |
Fast Facts Friday, February 17, 2023 | Take Quiz |
Fast Facts Friday, February 10, 2023 | Take Quiz |
Fast Facts Friday, February 3, 2023 | Take Quiz |
Fast Facts Friday, January 27, 2023 | Take Quiz |
Fast Facts Friday, January 20, 2023 | Take Quiz |
Fast Facts Friday, January 13, 2023 | Take Quiz |
Fast Facts Friday, January 6, 2023 | Take Quiz |
Fast Facts Friday, December 30, 2022 | Take Quiz |
Fast Facts Friday, December 23, 2022 | Take Quiz |
Fast Facts Friday, December 16, 2022 | Take Quiz |
Fast Facts Friday, December 9, 2022 | Take Quiz |
Fast Facts Friday, December 2, 2022 | Take Quiz |
Fast Facts Friday, November 25, 2022 | Take Quiz |
Fast Facts Friday, November 18, 2022 | Take Quiz |
Fast Facts Friday, November 11, 2022 | Take Quiz |
Fast Facts Friday, November 4, 2022 | Take Quiz |
Fast Facts Friday, October 28, 2022 | Take Quiz |
Fast Facts Friday, October 21, 2022 | Take Quiz |
Fast Facts Friday, October 14, 2022 | Take Quiz |
Fast Facts Friday, October 7, 2022 | Take Quiz |
Fast Facts Friday, September 30, 2022 | Take Quiz |
Fast Facts Friday, September 23, 2022 | Take Quiz |
Fast Facts Friday, September 16, 2022 | Take Quiz |
Fast Facts Friday, September 9, 2022 | Take Quiz |
Fast Facts Friday, September 2, 2022 | Take Quiz |
Fast Facts Friday, August 26, 2022 | Take Quiz |
Fast Facts Friday, August 19, 2022 | Take Quiz |
Fast Facts Friday August 12, 2022 | Take Quiz |
Fast Facts Friday, August 5, 2022 | Take Quiz |
Fast Facts Friday, July 29, 2022 | Take Quiz |
Fast Facts Friday, July 22, 2022 | Take Quiz |
Fast Facts Friday, July 15, 2022 | Take Quiz |
Fast Facts Friday, July 8, 2022 | Take Quiz |
Fast Facts Friday, July 1, 2022 | Take Quiz |
Fast Facts Friday, June 24, 2022 | Take Quiz |
Fast Facts Friday, June 17, 2022 | Take Quiz |
Fast Facts Friday, June 10, 2022 | Take Quiz |
Fast Facts Friday, June 3, 2022 | Take Quiz |
Fast Facts Friday, May 27, 2022 | Take Quiz |
Fast Facts Friday, May 20, 2022 | Take Quiz |
Fast Facts Friday, May 13, 2022 | Take Quiz |
Fast Facts Friday, May 6, 2022 | Take Quiz |
Fast Facts Friday, April 29, 2022 | Take Quiz |
Fast Facts Friday, April 22, 2022 | Take Quiz |
Fast Facts Friday, April 15, 2022 | Take Quiz |
Fast Facts Friday, April 8, 2022 | Take Quiz |
Fast Facts Friday, April 1, 2022 | Take Quiz |
Fast Facts Friday, March 25, 2022 | Take Quiz |
Fast Facts Friday, March 18, 2022 | Take Quiz |
Fast Facts Friday, March 11th, 2022 | Take Quiz |
Fast Facts Friday, March 4, 2022 | Take Quiz |
Fast Facts Friday, February 25, 2022 | Take Quiz |
Fast Facts Friday, February 18, 2022 | Take Quiz |
Fast Facts Friday, February 11th, 2022 | Take Quiz |
Fast Facts Friday, February 4th, 2022 | Take Quiz |
Fast Facts Friday, January 28th, 2022 | Take Quiz |
Fast Facts Friday, January 21, 2022 | Take Quiz |
Fast Facts Friday, January 14th, 2022 | Take Quiz |
Fast Facts Friday, January 7th, 2022 | Take Quiz |
Fast Facts Friday, December 31st, 2021 | Take Quiz |
Fast Facts Friday, December 24th, 2021 | Take Quiz |
Fast Facts Friday, December 17th, 2021 | Take Quiz |
Fast Facts Friday, December 10th, 2021 | Take Quiz |
Fast Facts Friday, December 3rd, 2021 | Take Quiz |
Fast Facts Friday, November 26th, 2021 | Take Quiz |
Fast Facts Friday, November 19th, 2021 | Take Quiz |
Fast Facts Friday, November 12th, 2021 | Take Quiz |
Fast Facts Friday, November 5th, 2021 | Take Quiz |
Fast Facts Friday, October 29th, 2021 | Take Quiz |
Fast Facts Friday, October 22nd, 2021 | Take Quiz |
Fast Facts Friday, October 15th, 2021 | Take Quiz |
Fast Facts Friday, October 8th, 2021 | Take Quiz |
Fast Facts Friday, October 1st, 2021 | Take Quiz |
Fast Facts Friday, September 24th, 2021 | Take Quiz |
Fast Facts Friday, September 17th, 2021 | Take Quiz |
Fast Facts Friday: September 10th, 2021 | Take Quiz |
Fast Facts Friday, September 3rd, 2021 | Take Quiz |
Fast Facts Friday, Aug 27th, 2021 | Take Quiz |
Fast Facts Friday, Aug 20th, 2021 | Take Quiz |
Fast Facts Friday: June 18, 2021 | Take Quiz |
Fast Facts Friday: April 16, 2021 | Take Quiz |
Fast Facts Friday: April 9, 2021 | Take Quiz |
Fast Facts Friday: April 2, 2021 | Take Quiz |
Fast Facts Friday: March 26, 2021 | Take Quiz |
Fast Facts Friday: March 19, 2021 | Take Quiz |
Fast Facts Friday: March 12, 2021 | Take Quiz |
Fast Facts Friday: March 5, 2021 | Take Quiz |
Fast Facts Friday: February 26, 2021 | Take Quiz |
Fast Facts Friday: February 19, 2021 | Take Quiz |
Fast Facts Friday: February 12, 2020 | Take Quiz |
Fast Facts Friday: February 5, 2021 | Take Quiz |
Fast Facts Friday: January 29, 2021 | Take Quiz |
Fast Facts Friday: January 22, 2021 | Take Quiz |
Fast Facts Friday: January 15, 2021 | Take Quiz |
Fast Facts Friday: January 8, 2021 | Take Quiz |
Fast Facts Friday: December 18, 2020 | Take Quiz |
Fast Facts Friday: December 11, 2020 | Take Quiz |
Fast Facts Friday: December 4th, 2020 | Take Quiz |
Fast Facts Friday: November 20, 2020 | Take Quiz |
Fast Facts Friday: November 13, 2020 | Take Quiz |
Fast Facts Friday: November 6, 2020 | Take Quiz |
Fast Facts Friday: October 30, 2020 | Take Quiz |
Fast Facts Friday: October 23, 2020 | Take Quiz |
Fast Facts Friday: October 16, 2020 | Take Quiz |
Fast Facts Friday: October 9, 2020 | Take Quiz |
Fast Facts Friday: October 2, 2020 | Take Quiz |
Fast Facts Friday: September 25, 2020 | Take Quiz |
Fast Facts Friday: September 18, 2020 | Take Quiz |
Fast Facts Friday: September 11, 2020 | Take Quiz |
Fast Facts Friday: September 4, 2020 | Take Quiz |
Fast Facts Friday: August 28, 2020 | Take Quiz |
Fast Facts Friday: August 21, 2020 | Take Quiz |
Fast Facts Friday: August 14, 2020 | Take Quiz |
Fast Facts Friday: August 7, 2020 | Take Quiz |
Fast Facts Friday: July 31, 2020 | Take Quiz |
Fast Facts Friday: July 24, 2020 | Take Quiz |
Fast Facts Friday: July 17, 2020 | Take Quiz |
Fast Facts Friday: July 10, 2020 | Take Quiz |
Fast Facts Friday: July 3, 2020 | Take Quiz |
Fast Facts Friday: June 26, 2020 | Take Quiz |
Fast Facts Friday: June 19, 2020 | Take Quiz |
Fast Facts Friday: June 12, 2020 | Take Quiz |
Fast Facts Friday: June 5, 2020 | Take Quiz |
Fast Facts Friday: May 29th, 2020 | Take Quiz |
Fast Facts Friday: May 22, 2020 | Take Quiz |
Fast Facts Friday: May 15, 2020 | Take Quiz |
Fast Facts Friday: May 8, 2020 | Take Quiz |
Fast Facts Friday: March 13, 2020 | Take Quiz |
Fast Facts Friday: March 6, 2020 | Take Quiz |
Fast Facts Friday: February 28, 2020 | Take Quiz |
Fast Facts Friday: October 4, 2019 | Take Quiz |
Fast Facts Friday: September 27, 2019 | Take Quiz |
Fast Facts Friday: August 30, 2019 | Take Quiz |
Fast Facts Friday: May 24, 2019 | Take Quiz |
Fast Facts Friday: May 17, 2019 | Take Quiz |
Fast Facts Friday: May 10, 2019 | Take Quiz |
Fast Facts Friday: May 3, 2019 | Take Quiz |
Fast Facts Friday: April 26, 2019 | Take Quiz |
Fast Facts Friday: April 19, 2019 | Take Quiz |
Fast Facts Friday: April 12, 2019 | Take Quiz |
Fast Facts Friday: April 5, 2019 | Take Quiz |
Fast Facts Friday: March 29, 2019 | Take Quiz |
Fast Facts Friday: March 22, 2019 | Take Quiz |
Fast Facts Friday: March 15, 2019 | Take Quiz |
Fast Facts Friday: March 8, 2019 | Take Quiz |
Fast Facts Friday: March 1, 2019 | Take Quiz |
Fast Facts Friday: February 22, 2019 | Take Quiz |
Fast Facts Friday: February 15, 2019 | Take Quiz |
Fast Facts Friday: February 8, 2019 | Take Quiz |
Fast Facts Friday: February 1, 2019 | Take Quiz |
Ovarian Cancer
Ovarian Cancer
Quiz | |
---|---|
Ovarian Cancer Presentation and Diagnosis | Take Quiz |
Ovarian Cancer and Obesity | Take Quiz |
Ovarian Cancer Subtypes | Take Quiz |
Ovarian Cancer Surgical Complications | Take Quiz |
Ovarian Cancer Risk Factors | Take Quiz |
Ovarian Cancer Guidelines | Take Quiz |
Breast Cancer
Breast Cancer
Quiz | |
---|---|
Breast Cancer Diagnosis | Take Quiz |
Breast Cancer Exercise Interventions | Take Quiz |
Venous Access Ports in Breast Cancer | Take Quiz |
Male Breast Cancer | Take Quiz |
Breast Cancer Risk Factors | Take Quiz |
SABCS 2021: Efficacy of selective estrogen receptor degrader in estrogen receptor–positive breast cancer | Take Quiz |
Breast cancer and gut microbiota | Take Quiz |
Breast cancer and gut microbiota | Take Quiz |
Lobular and ductal breast carcinoma | Take Quiz |
Breast cancer subtype treatment and outcomes | Take Quiz |
Breast cancer diagnosis | Take Quiz |
Breast cancer types | Take Quiz |
Breast cancer screening | Take Quiz |
Neoadjuvant therapy in breast cancer | Take Quiz |
Genetic risk for breast cancer by race in the U.S. | Take Quiz |
Advanced breast cancer among women in the United States | Take Quiz |
Breast cancer mortality trends in the US | Take Quiz |
Breast cancer metastasis | Take Quiz |
Breast-conserving surgery for breast cancer | Take Quiz |
Types of mastectomy for breast cancer | Take Quiz |
Performing biopsy in breast cancer diagnosis | Take Quiz |
Regional nodal irradiation in breast cancer management | Take Quiz |
Breast cancer risk among US women | Take Quiz |
MRI for breast cancer screening | Take Quiz |
Clinical signs and symptoms of breast cancer | Take Quiz |
Breast cancer prognoses | Take Quiz |
Breast tissue density and cancer risk | Take Quiz |
Modifiable breast cancer risk factors | Take Quiz |
Personal and family history in breast cancer risk | Take Quiz |
Breast cancer risk | Take Quiz |
Breast cancer metabolic tumor volume and endocrine therapy effectiveness | Take Quiz |
Life-years impact of metastatic breast cancer among US women | Take Quiz |
Bisphosphonate treatment and breast cancer | Take Quiz |
USPSTF Recommendations: Breast cancer genetic risk assessment | Take Quiz |
Prognostic factors for HR-positive HER2-negative breast cancer | Take Quiz |
Early stage breast cancer and endocrine therapy | Take Quiz |
Partial vs. whole breast irradiation in cancer management | Take Quiz |
Early stage breast cancer | Take Quiz |
Breast cancer: Types of surgery | Take Quiz |
Circulating tumor cell clusters and metastatic breast cancer outcomes | Take Quiz |
Breast cancer with leptomeningeal metastasis: Characteristics & outcomes | Take Quiz |
De novo metastatic breast cancer: Occurrence & outcome by subtype | Take Quiz |
Metastatic breast cancer: Adapting to changes during treatment | Take Quiz |
Breast cancer: Tissue diagnosis & imaging studies | Take Quiz |
Early & advanced breast cancer: Use of imaging in evaluation & follow-up | Take Quiz |
Breast cancer: Circulating tumor cells | Take Quiz |
Metastatic breast cancer with ESR1 mutation: Clinical management considerations | Take Quiz |
ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
ASCO/CAP Guidelines: HER2 and FISH testing | Take Quiz |
Factors related to breast cancer surgery choices | Take Quiz |
Obesity & postmenopausal breast cancer risk | Take Quiz |
Breast conservation & neoadjuvant therapy | Take Quiz |
Oophorectomy & breast cancer | Take Quiz |
Quiz | |
---|---|
B-Cell Lymphoma Relapse | Take Quiz |
Fast Facts Friday, Aug 13th, 2021 | Take Quiz |
Fast Facts Friday, Aug 6th, 2021 | Take Quiz |
Fast Facts Friday, July 30, 2021 | Take Quiz |
Fast Facts Friday July 23, 2021 | Take Quiz |
Fast Facts Friday: July 16, 2021 | Take Quiz |
Fast Facts Friday - 07/09/2021 | Take Quiz |
Fast Facts Friday July 2, 2021 | Take Quiz |
Fast Facts Friday June 25, 2021 | Take Quiz |
Diagnose It: November 28, 2020 | Take Quiz |
Transformed indolent lymphoma and ASCT | Take Quiz |
Genes & AML | Take Quiz |
ALL outcomes in pediatric patients | Take Quiz |
Guideline updates for non-Hodgkin lymphomas: Part 2 | Take Quiz |
Guideline updates for non-Hodgkin lymphomas: Part 1 | Take Quiz |
Classification of adult ALL | Take Quiz |
HIV-related lymphomas and AHCT | Take Quiz |
Adult HL treatment | Take Quiz |
Diagnosis and assessment of ALL | Take Quiz |
Guideline updates for non-Hodgkin lymphomas: Part 3 | Take Quiz |
Staging of adult HL | Take Quiz |
Treatment of adult ALL | Take Quiz |
Screening & prevention of head & neck cancer | Take Quiz |
Prognosis of head & neck cancer | Take Quiz |
Epidemiology & risk factors associated with head & neck cancer | Take Quiz |
Diagnosis & staging of head & neck cancer | Take Quiz |
Diagnosis & management of infectious disease syndromes | Take Quiz |
Evaluation of a neutropenic patient with fever | Take Quiz |
Myelodysplastic syndrome | Take Quiz |
Therapeutic approaches to myelodysplastic syndrome | Take Quiz |
B Cell Lymphoma
B Cell Lymphoma
Quiz | |
---|---|
Mantle Cell Lymphoma | Take Quiz |
CAR T-Cell Therapy in B Cell Lymphoma | Take Quiz |
Diffuse Large B-Cell Lymphoma | Take Quiz |
AML
AML
Quiz | |
---|---|
Acute Myeloid Leukemia Overview | Take Quiz |
Acute myeloid leukemia prognosis | Take Quiz |
Clinical evaluation for acute myeloid leukemia | Take Quiz |
AML prevalence and onset risk | Take Quiz |
Managing acute myeloid leukemia | Take Quiz |
Management of acute myeloid leukemia | Take Quiz |
Clinical features of acute myeloid leukemia | Take Quiz |
Clonal hematopoiesis & risk for therapy-related cancer | Take Quiz |
AML: Androgen maintenance therapy & survival | Take Quiz |
Leukemia: Survival after cord-blood transplant | Take Quiz |
Telomere length and delayed bone marrow recovery in pediatric AML | Take Quiz |
Extramedullary disease & AML survival | Take Quiz |
Hematologic Malignancies
Hematologic Malignancies
Quiz | |
---|---|
Acute Myeloid Leukemia Overview | Take Quiz |
Antihistamine use for CLL cell death | Take Quiz |
COVID-19 in patients with CLL | Take Quiz |
Diagnosing CLL | Take Quiz |
CLL presentation | Take Quiz |
CLL management & prognosis | Take Quiz |
CLL: Risk factors & epidemiology | Take Quiz |
Diagnosis of CLL | Take Quiz |
Mixed Topics
Mixed Topics
Quiz | |
---|---|
Cardiotoxicity from Cancer Treatment | Take Quiz |
Late Effects of Anticancer Therapy in Childhood Cancer Survivors | Take Quiz |
Prostate Cancer
Prostate Cancer
Quiz | |
---|---|
Prostate Cancer Considerations | Take Quiz |
Prostate Cancer Recent Studies | Take Quiz |
Lifestyle
Lifestyle
Quiz | |
---|---|
Diet and Cancer | Take Quiz |
Head & Neck/Thyroid Cancers
Head & Neck/Thyroid Cancers
Quiz | |
---|---|
Diagnosis of Papillary Thyroid Cancer | Take Quiz |
Thyroid Cancer Presentation and Evaluation | Take Quiz |
Medullary Thyroid Cancer | Take Quiz |
Thyroid Cancer Metastasis | Take Quiz |
Atrial Fibrillation and Other Cardiac Concerns in Thyroid Cancer | Take Quiz |
Thyroid Cancer Risk Factors | Take Quiz |
ESMO Thyroid Cancer Treatment Guidelines | Take Quiz |
Pediatric Thyroid Cancer | Take Quiz |
Thyroid Cancer Diagnosis | Take Quiz |
Thyroid carcinoma types | Take Quiz |
ATA Guidelines: Histopathologic evaluation of thyroidectomy samples in patients with DTC | Take Quiz |
ATA Guidelines: Secretory products & morphological examination of MTC | Take Quiz |
ATA Guidelines: Intraoperative voice and parathyroid management & follow-up in patients with DTC | Take Quiz |
ATA Guidelines: Voice and parathyroid issues in DTC | Take Quiz |
ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
Thyroid cancer trends in the United States | Take Quiz |
DTC detection in obese and non-obese patients | Take Quiz |
Staging: Papillary & follicular thyroid cancer | Take Quiz |
Prognostic & risk factors of thyroid cancer | Take Quiz |
Thyroid nodules & thyroid metastases | Take Quiz |
Postoperative treatment of WDTC | Take Quiz |
Recurrent thyroid cancer | Take Quiz |
Thyroid gland malignancies: DTC, MTC, & ATC | Take Quiz |
Surgical treatment: Stage III & IV papillary & follicular thyroid cancer | Take Quiz |
The breast-thyroid cancer link | Take Quiz |
ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
Impact of low iodine diet in DTC | Take Quiz |
ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
Epidemiology & clinical presentation of parathyroid carcinoma | Take Quiz |
Diagnosis & treatment of parathyroid carcinoma | Take Quiz |
Diagnosis & treatment of medullary thyroid cancer | Take Quiz |
Thyroid cancer outcomes | Take Quiz |
Clinical presentation & diagnosis of thyroid cancer | Take Quiz |
ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
Surgical treatment of primary stage differentiated thyroid cancer | Take Quiz |
Treatment of differentiated thyroid cancer | Take Quiz |
Types of differentiated thyroid cancer | Take Quiz |
COVID-19 Updates
COVID-19 Updates
Quiz | |
---|---|
COVID-19 Brain Fog | Take Quiz |
Long COVID | Take Quiz |
COVID-19 Diagnosis | Take Quiz |
Blood glucose level and COVID-19 hospitalizations | Take Quiz |
Risk for COVID-19 by type of cancer diagnosis | Take Quiz |
Providing clinical services during COVID-19 | Take Quiz |
Renal Cell Carcinoma
Renal Cell Carcinoma
Quiz | |
---|---|
Sarcomatoid Renal Cell Carcinoma | Take Quiz |
Ablation in Renal Cell Carcinoma | Take Quiz |
Brain Metastasis in Renal Cell Carcinoma | Take Quiz |
Chromophobe Renal Cell Carcinoma | Take Quiz |
Renal Cell Carcinoma Comorbidities | Take Quiz |
Kidney Transplantation in Renal Cell Carcinoma | Take Quiz |
Renal Cell Carcinoma Treatment Guidelines | Take Quiz |
Renal Cell Carcinoma Treatment | Take Quiz |
Clear Cell Papillary Renal Cell Carcinoma | Take Quiz |
Renal cell carcinoma and bone metastasis | Take Quiz |
Renal cell carcinoma risk factors | Take Quiz |
Renal cell carcinoma diagnosis | Take Quiz |
Renal cell carcinoma in children | Take Quiz |
Renal cell carcinoma metastasis | Take Quiz |
Chromophobe renal cell carcinoma | Take Quiz |
Renal cell carcinoma diagnosis and therapy options | Take Quiz |
BAP1 protein expression in clear cell RCC | Take Quiz |
Staging and manifestation of RCC in patients | Take Quiz |
Prognosis of renal cell carcinoma | Take Quiz |
Diagnosis of renal cell carcinoma | Take Quiz |
Features of renal cell carcinoma | Take Quiz |
Managing clear cell renal cell carcinoma metastases | Take Quiz |
Renal cell carcinoma recurrence by histological subtype | Take Quiz |
Managing localized renal cell carcinoma | Take Quiz |
Renal cell carcinoma prognosis | Take Quiz |
Renal cell carcinoma risk factors | Take Quiz |
Imaging of metastatic renal cell carcinoma | Take Quiz |
ASCO Guidelines: Management of renal cell masses | Take Quiz |
RCC subtypes: Risk factors, clinical findings, & imaging | Take Quiz |
Common RCC subtypes | Take Quiz |
AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
Staging & surveillance of RCC | Take Quiz |
Minimally invasive surgery for RCC | Take Quiz |
Pathophysiology & prognosis of RCC | Take Quiz |
Unique patient categories in RCC | Take Quiz |
Management of localized RCC | Take Quiz |
Lung Cancer
Lung Cancer
Quiz | |
---|---|
New Lung Cancer Biomarkers | Take Quiz |
Lung Metastasis | Take Quiz |
Lung cancer and nonsmoking risk factors | Take Quiz |
Lung cancer symptoms and signs | Take Quiz |
Non–small cell lung cancer subtypes and features | Take Quiz |
Lung cancer risk in other disease states | Take Quiz |
Non–small cell lung cancer and treatment evolution | Take Quiz |
Non–small cell lung cancer and treatment evolution | Take Quiz |
Small cell lung cancer immunotherapy and outcomes | Take Quiz |
Lung cancer screening methods | Take Quiz |
Small cell lung cancer and non–small cell lung cancer diagnosis | Take Quiz |
Non-small cell lung cancer | Take Quiz |
Lung cancer risk factors | Take Quiz |
Non-small cell lung cancer; types and characteristics | Take Quiz |
Screening of lung cancer in patients | Take Quiz |
Lung cancer evaluation | Take Quiz |
Post-treatment morbidity in lung cancer | Take Quiz |
Surgical management of lung cancer brain metastases | Take Quiz |
Small cell and non-small cell cancer | Take Quiz |
Malnutrition and sarcopenia in lung cancer | Take Quiz |
Lung cancer prognosis factors | Take Quiz |
COVID-19 and lung cancer | Take Quiz |
Surgical management of NSCLC | Take Quiz |
Lung cancer and serum carcinoembryonic antigen | Take Quiz |
NSCLC staging with lymph node involvement | Take Quiz |
Low-dose CT screening for lung cancer | Take Quiz |
Guidelines: Lung cancer screening during COVID-19 | Take Quiz |
Postoperative radiotherapy for NSCLC with N2 disease | Take Quiz |
Incidence and prognosis of second lung cancer | Take Quiz |
Trends in lung cancer mortality | Take Quiz |
Lung cancer screening for high-risk patients | Take Quiz |
Stereotactic ablative radiotherapy for NSCLC | Take Quiz |
Radiomics in lung cancer evaluation | Take Quiz |
Benefits and risks of lung cancer screening | Take Quiz |
Clinical methods of lung cancer detection | Take Quiz |
Lung cancer risk and screening | Take Quiz |
Principles in treating advanced non-small cell lung cancer | Take Quiz |
Clinical features of lung cancer | Take Quiz |
Prognosis in patients with lung cancer | Take Quiz |
Treating stage III non-small cell lung cancer | Take Quiz |
Lung function post-radiotherapy for stage III non-small cell lung cancer | Take Quiz |
Stage IIIA non-small cell lung cancer | Take Quiz |
Palliative radiotherapy for stage III non-small-cell lung cancer | Take Quiz |
Treatment effectiveness in stage III non-small cell lung cancer | Take Quiz |
Inoperable stage III non-small cell lung cancer | Take Quiz |
Squamous-cell lung cancer biomarkers | Take Quiz |
NSCLC: Delayed chemo & survival after surgery | Take Quiz |
Lung cancer: The role of imaging studies & chest CT | Take Quiz |
Understanding lung cancer | Take Quiz |
Advanced & previously treated NSCLC: The OAK & POPLAR trials by Bobby Daly, MD, MBA | Take Quiz |
PD-L1-Positive NSCLC and KEYNOTE-024, by Bobby Daly, MD, MBA | Take Quiz |
Pathology & clinical presentation of small cell lung cancer | Take Quiz |
Staging & imaging of small cell lung cancer | Take Quiz |
Treatment of stage IIIA NSCLCs | Take Quiz |
RAS mutations in NSCLC by Kevin Wood, MD | Take Quiz |
Treatment of early-stage NSCLCs | Take Quiz |
Clinical evaluation of single pulmonary nodules | Take Quiz |
NSCLC risk and subtypes | Take Quiz |
Lung cancer pathology | Take Quiz |
Conference Coverage
Conference Coverage
Quiz | |
---|---|
SABCS 2021: Efficacy of selective estrogen receptor degrader in estrogen receptor–positive breast cancer | Take Quiz |
SABCS 2021: Breast cancer risk factors | Take Quiz |
SABCS 2021: Breast cancer and liquid biopsy | Take Quiz |
SABCS 2021: Triple-negative breast cancer and its features | Take Quiz |
SABCS 2021: Inflammatory breast cancer features | Take Quiz |
SABCS 2021: Breast cancer mortality and recurrence | Take Quiz |
ASCO Conference: Survival outcomes in untreated metastatic breast cancer | Take Quiz |
ASCO Conference: U.S. breast cancer mortality by molecular subtype | Take Quiz |
ASCO Conference: Chemotherapy for breast cancer | Take Quiz |
ASCO Conference: Inflammatory cytokines and breast cancer recurrence | Take Quiz |
ASCO Conference: Managing breast cancer during pregnancy | Take Quiz |
ASCO Annual Meeting: Patient race and distant metastases in breast cancer | Take Quiz |
ASH 2020: Effectiveness of ibrutinib and venetoclax in CLL/SLL cases | Take Quiz |
ASH 2020: Multiple myeloma responses to novel CAR T-cell constructs | Take Quiz |
ASH 2020: Transplant for myelodysplastic syndrome in elderly patients | Take Quiz |
ASH 2020: Neurocognitive impairment in pediatric Hodgkin lymphoma survivors | Take Quiz |
ASH 2020: Allogenic transplant effectiveness in T-cell lymphomas | Take Quiz |
ASH 2020: Hematologic disease and COVID-19 | Take Quiz |
Hodgkin Lymphoma
Hodgkin Lymphoma
Quiz | |
---|---|
Classic Hodgkin lymphoma and immune checkpoint inhibitor therapy | Take Quiz |
Classic Hodgkin lymphoma pathology | Take Quiz |
Classic Hodgkin lymphoma & CNS involvement | Take Quiz |
Lymphocyte-depleted classic Hodgkin lymphoma | Take Quiz |
Classical Hodgkin lymphoma features and diagnosis | Take Quiz |
Diagnosis of classical Hodgkin lymphoma | Take Quiz |
Features of classical Hodgkin lymphoma | Take Quiz |
Relapsed/refractory classical Hodgkin lymphoma | Take Quiz |
Lymphocyte depleted classic Hodgkin lymphoma | Take Quiz |
Tumor tissue in classical Hodgkin’s lymphoma | Take Quiz |
Thymus and activation-regulated chemokine in classical Hodgkin lymphoma | Take Quiz |
Classical Hodgkin lymphoma and patient age | Take Quiz |
Treatment of advanced-stage classical Hodgkin lymphoma | Take Quiz |
Treatment of early-stage classical Hodgkin lymphoma | Take Quiz |
Biopsy for classical Hodgkin lymphoma diagnosis | Take Quiz |
Bulky disease in classical Hodgkin lymphoma | Take Quiz |
Subtypes of classical Hodgkin lymphoma | Take Quiz |
Patient age in classical Hodgkin lymphoma | Take Quiz |
Managing classical Hodgkin lymphoma | Take Quiz |
Frontline management of classical Hodgkin lymphoma | Take Quiz |
Clinical manifestation of lymphocyte-depleted cHL | Take Quiz |
Classical Hodgkin lymphoma incidence and management | Take Quiz |
Classical Hodgkin lymphoma subtypes among HL cases | Take Quiz |
Lymphocyte depleted and mixed-cellularity CHL | Take Quiz |
Relapsed/refractory classical Hodgkin lymphoma treatments | Take Quiz |
Standard of care in relapsed/refractory classical Hodgkin lymphoma | Take Quiz |
Clinical burden of classical Hodgkin lymphoma | Take Quiz |
Clinical effects of the microenvironment in cHL | Take Quiz |
Difficulties in clinical management of classic Hodgkin lymphoma | Take Quiz |
Tumor microenvironment macrophages in classical HL | Take Quiz |
Treatment effectiveness in classic Hodgkin lymphoma | Take Quiz |
Bone marrow involvement in cHL | Take Quiz |
Treating relapsed classical Hodgkin’s lymphoma | Take Quiz |
HIV infection and classical Hodgkin lymphoma | Take Quiz |
Treatment of relapsed-refractory classical Hodgkin lymphoma | Take Quiz |
Cellular-level features in classical Hodgkin’s lymphoma | Take Quiz |
Laboratory diagnostic testing for classical Hodgkin lymphoma | Take Quiz |
Stem-cell transplantation effectiveness in refractory classical Hodgkin lymphoma | Take Quiz |
Prognostic factors in classical Hodgkin lymphoma | Take Quiz |
Post-treatment outcomes in classical Hodgkin lymphoma | Take Quiz |
Overview of classical Hodgkin lymphoma | Take Quiz |
Radiation therapy in treatment of classic Hodgkin lymphoma | Take Quiz |
Diagnosis of Hodgkin lymphoma | Take Quiz |
Hodgkin lymphoma risk and prognostic factors | Take Quiz |
Genitourinary Cancer
Genitourinary Cancer
Quiz | |
---|---|
Bladder cancer presentation | Take Quiz |
Laboratory findings in pheochromocytoma diagnosis | Take Quiz |
Obesity and cancer incidence | Take Quiz |
ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
RCC subtypes: Risk factors, clinical findings, & imaging | Take Quiz |
AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
Common RCC subtypes | Take Quiz |
AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
Testicular cancer: Staging & risk stratification | Take Quiz |
AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
AHRQ Review: Management of renal masses & localized renal cancer | Take Quiz |
Understanding urethral cancer | Take Quiz |
Staging & surveillance of RCC | Take Quiz |
Minimally invasive surgery for RCC | Take Quiz |
Pathophysiology & prognosis of RCC | Take Quiz |
Risk factors & clinical features of bladder cancer | Take Quiz |
Unique patient categories in RCC | Take Quiz |
Management of localized RCC | Take Quiz |
Serum tumor markers & testicular cancer | Take Quiz |
Epidemiology & risk factors associated with testicular cancer | Take Quiz |
AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
Clinical features and pathology of bladder cancer | Take Quiz |
Treatment options for stage I & II RCC | Take Quiz |
Treatment options for RCC | Take Quiz |
RCC tumor characterization: Laboratory & imaging studies | Take Quiz |
Genetic risk factors associated with RCC | Take Quiz |
RCC subtypes | Take Quiz |
Pathology & natural history of renal cancer | Take Quiz |
RCC: Links & risk factors | Take Quiz |
Clinical features & management of RCC | Take Quiz |
Epidemiology & etiology of RCC | Take Quiz |
Risk factors and pathology of prostate cancer | Take Quiz |
Prostate cancer: Disease detection | Take Quiz |
Diagnosis & prognosis of bladder cancer | Take Quiz |
Classification of renal cell cancer | Take Quiz |
Staging of testicular cancer | Take Quiz |
Risk factors & prostate cancer | Take Quiz |
ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
Survival in advanced prostate cancer | Take Quiz |
Understanding bladder cancer | Take Quiz |
Treatment of prostate cancer | Take Quiz |
T Cell Lymphomas
T Cell Lymphomas
Quiz | |
---|---|
PTCL subtypes and features | Take Quiz |
Role of epigenetics in PTCL diagnosis and treatment | Take Quiz |
Epigenetic alterations in PTCL development | Take Quiz |
Peripheral T‐cell lymphoma prognosis | Take Quiz |
Relapsed peripheral T-cell lymphoma | Take Quiz |
Adult T-cell leukemia-lymphoma | Take Quiz |
Peripheral T-cell lymphoma risk factors | Take Quiz |
Prognosis of peripheral T-cell lymphomas | Take Quiz |
ALK positive/negative anaplastic large cell lymphomas | Take Quiz |
Extranodal natural killer/T-cell lymphoma prognosis | Take Quiz |
Diagnosing angioimmunoblastic T cell lymphoma | Take Quiz |
Breast implant-associated anaplastic large cell lymphoma | Take Quiz |
Managing angioimmunoblastic T cell lymphoma | Take Quiz |
Risk and management of peripheral T cell lymphomas | Take Quiz |
Lab diagnosis of peripheral T-cell lymphoma | Take Quiz |
Peripheral T-cell lymphoma manifestations | Take Quiz |
Angioimmunoblastic T-cell lymphoma | Take Quiz |
Identifying indolent peripheral T-cell lymphomas | Take Quiz |
Peripheral T-cell lymphoma outcomes | Take Quiz |
Anaplastic large cell lymphoma | Take Quiz |
Enteropathy-associated T cell lymphoma | Take Quiz |
Standard approaches in peripheral T cell lymphoma treatment | Take Quiz |
Biomarkers for peripheral T cell lymphoma not otherwise specified | Take Quiz |
Peripheral T-cell lymphoma subtype clinical features | Take Quiz |
Peripheral T-cell lymphoma treatment outcomes | Take Quiz |
Physical findings of mycosis fungoides | Take Quiz |
Gynecologic Cancer
Gynecologic Cancer
Quiz | |
---|---|
Guideline-adherent endometrial cancer treatment in the U.S. | Take Quiz |
Common classifications of ovarian cancer tumors | Take Quiz |
Ovarian cancer prognosis and outcomes | Take Quiz |
Oral contraceptive use and ovarian cancer risk | Take Quiz |
Genetics and ovarian cancer | Take Quiz |
Diagnosing ovarian cancer | Take Quiz |
Chemotherapy for ovarian cancer | Take Quiz |
Ovarian cancer management during COVID-19 | Take Quiz |
Surgical ovarian cancer management | Take Quiz |
Ovarian cancer management | Take Quiz |
Ovarian cancer screening | Take Quiz |
Tumor markers in ovarian cancer evaluation | Take Quiz |
Ovarian cancer risk factors | Take Quiz |
Ovarian cancer signs and symptoms | Take Quiz |
Managing advanced high-grade serous ovarian cancer | Take Quiz |
Recent trends in advanced epithelial ovarian cancer management | Take Quiz |
Transvaginal ultrasound for evaluating ovarian masses | Take Quiz |
Benign vs malignant ovarian masses | Take Quiz |
Clinical outcomes in high-grade serous ovarian cancer | Take Quiz |
Salpingo-oophorectomy and ovarian cancer risk | Take Quiz |
Tumor factors in epithelial ovarian cancer outcomes | Take Quiz |
Managing ovarian cancer | Take Quiz |
Capsule rupture risk with surgery in early-stage ovarian cancer | Take Quiz |
Breastfeeding and ovarian cancer risk | Take Quiz |
Ovarian cancer risk from biochemical intakes and exposures | Take Quiz |
Risk factors for ovarian cancer | Take Quiz |
Type I and type II tumors in ovarian carcinoma | Take Quiz |
Clinical aspects of ovarian cancer | Take Quiz |
Cervical cancer screening in the United States | Take Quiz |
Cancer risk after cervical intraepithelial neoplasia treatment | Take Quiz |
Cervicovaginal microbiome and cervical cancer screening | Take Quiz |
Cervical intraepithelial neoplasia interventions | Take Quiz |
Cervical cancer development precursors | Take Quiz |
Diagnostic imaging for cervical cancer evaluation | Take Quiz |
Ultrasonography findings and ovarian cancer risk | Take Quiz |
Ovarian cancer treatment | Take Quiz |
Parity and ovarian cancer risk | Take Quiz |
Ovarian cancer risk factors | Take Quiz |
ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
ASCO Guidelines: Cervical cancer screening | Take Quiz |
Subtypes of endometrial cancer | Take Quiz |
Screening & serum biomarkers for EOC | Take Quiz |
Prevention of EOC with RRSO | Take Quiz |
Diagnosis, evaluation, and treatment of EOC | Take Quiz |
Diagnosis & screening of endometrial cancer | Take Quiz |
Risk factors and screening for endometrial cancer | Take Quiz |
Prevention and screening of ovarian cancer | Take Quiz |
EOC pathology | Take Quiz |
Nodal spread and endometrial cancer | Take Quiz |
Bleeding Disorders
Bleeding Disorders
Quiz | |
---|---|
Hemophilia-associated pain | Take Quiz |
Guidelines: Bleeding management in von Willebrand disease | Take Quiz |
Bone mineral density and severe hemophilia A | Take Quiz |
Immune thrombocytopenia features | Take Quiz |
Diagnosing von Willebrand disease | Take Quiz |
Evans syndrome | Take Quiz |
Hypercoagulable states: Clinical features | Take Quiz |
Pancytopenia: Patient history & features | Take Quiz |
Sickle cell trait and HBA1c in African Americans | Take Quiz |
Hemophilia A and B: Characteristics & diagnosis | Take Quiz |
Sickle cell trait, rhabdomyolysis, and mortality | Take Quiz |
NHF Guideline: Hemophilia care models | Take Quiz |
Classification of von Willebrand disease | Take Quiz |
Treatment of von Willebrand disease | Take Quiz |
Pathophysiology of hemophilia A and B | Take Quiz |
Clinical manifestations of hemophilia | Take Quiz |
GVHD: Laboratory & imaging studies | Take Quiz |
GI Oncology
GI Oncology
Quiz | |
---|---|
Colon cancer management decisions | Take Quiz |
Colorectal cancer risk factors | Take Quiz |
Managing liver metastases in colon cancer | Take Quiz |
Colorectal cancer prognosis markers | Take Quiz |
Adenomas and colorectal cancer | Take Quiz |
Esophageal adenocarcinoma onset trends | Take Quiz |
Malignant colorectal polyps: Best practices | Take Quiz |
Treating severe thrombocytopenia in HCC | Take Quiz |
Pancreatic cancer screening in high-risk individuals | Take Quiz |
Glycated hemoglobin levels and risk of pancreatic cancer | Take Quiz |
NAFLD and hepatocellular carcinoma risk | Take Quiz |
Hepatocellular carcinoma screening in NAFLD | Take Quiz |
USPSTF Recommendation: Pancreatic cancer screening | Take Quiz |
Adenomas and CRC risk | Take Quiz |
Colorectal cancer trends in the United States | Take Quiz |
Pancreatic neuroendocrine tumors: Pathogenesis & prognostic factors | Take Quiz |
Colorectal cancer & endoscopic resection | Take Quiz |
USPSTF Guidelines: Update on CRC screening | Take Quiz |
Risk factors & screening for gastric cancers | Take Quiz |
Diagnostic laparoscopy & management of PDA | Take Quiz |
Management of PDA & metastatic disease | Take Quiz |
Treatment of esophageal cancer | Take Quiz |
Pathology & staging workup of esophageal cancer | Take Quiz |
Diagnosing PDA: Imaging & aspiration/biopsy | Take Quiz |
Clinical presentation & diagnosis of esophageal cancer | Take Quiz |
Epidemiology & etiology of esophageal cancer | Take Quiz |
Gastric cancer prevention | Take Quiz |
Rectal cancer: Neoadjuvant therapy vs surgery | Take Quiz |
Adenoma detection rates in CRC | Take Quiz |
Preoperative chemotherapy & colorectal cancer | Take Quiz |
Familial adenomatous polyposis & CRC | Take Quiz |
Screening of CRC | Take Quiz |
Colonoscopy: Optimizing adequate bowel cleansing | Take Quiz |
ASCO Guidelines: Surveillance protocol for survivors of CRC | Take Quiz |
Epidemiology & risk factors of CRC | Take Quiz |
Genetic evaluation & management of Lynch syndrome | Take Quiz |
Laparoscopic resection vs surgery for rectal cancer | Take Quiz |
Risk factors & prognosis of rectal cancer | Take Quiz |
Understanding hereditary CRC syndromes: Part 2 | Take Quiz |
Colorectal cancer screening: Flexible sigmoidoscopy | Take Quiz |
Pediatrics
Pediatrics
Quiz | |
---|---|
Febrile neutropenia in pediatric cancer | Take Quiz |
Pediatric cancer treatment effects | Take Quiz |
Sun protection behavior among pediatric hematopoietic stem cell transplants patients | Take Quiz |
Pediatric cancer and risk of CVD | Take Quiz |
Von Hippel-Lindau disease | Take Quiz |
Gastrointestinal Cancer
Gastrointestinal Cancer
Quiz | |
---|---|
Aspirin and colorectal cancer risk | Take Quiz |
Transplant
Transplant
Quiz | |
---|---|
Managing chronic graft-versus-host disease | Take Quiz |
Photo Quizzes
Photo Quizzes
Quiz | |
---|---|
Diagnose It: April 10, 2021 | Take Quiz |
Diagnose It: March 27, 2021 | Take Quiz |
Diagnose It: March 13, 2021 | Take Quiz |
Diagnose It: February 27, 2021 | Take Quiz |
Diagnose It: February 6, 2021 | Take Quiz |
Diagnose It: December 11, 2020 | Take Quiz |
Diagnose It: November 13, 2020 | Take Quiz |
Diagnose It: October 31, 2020 | Take Quiz |
Diagnose It: October 17, 2020 | Take Quiz |
Diagnose It: September 26, 2020 | Take Quiz |
Diagnose It: September 5, 2020 | Take Quiz |
Diagnose It: August 22, 2020 | Take Quiz |
Diagnose It: August 8, 2020 | Take Quiz |
Diagnose It: July 25, 2020 | Take Quiz |
Diagnose It | Take Quiz |
Melanoma
Melanoma
Quiz | |
---|---|
Autoimmune disease in melanoma | Take Quiz |
Systemic sclerosis and cancer risk | Take Quiz |
Artificial UV radiation and second melanoma | Take Quiz |
Etiology & presentation of squamous cell carcinoma | Take Quiz |
Uveal choroidal melanoma | Take Quiz |
Management of metastatic melanoma | Take Quiz |
Adjuvant treatment of melanoma | Take Quiz |
Melanoma early diagnosis and staging | Take Quiz |
Melanoma risk factors | Take Quiz |
Melanoma: Epidemiology & etiology | Take Quiz |
Clinical features of melanoma | Take Quiz |
Multiple Myeloma
Multiple Myeloma
Quiz | |
---|---|
Clinical evaluation of multiple myeloma | Take Quiz |
Treatment burden in multiple myeloma | Take Quiz |
Multiple myeloma treatment access and survival in the US | Take Quiz |
Managing successive relapses in multiple myeloma | Take Quiz |
Managing first relapse in multiple myeloma | Take Quiz |
Treating newly diagnosed multiple myeloma | Take Quiz |
Statin use and survival in multiple myeloma | Take Quiz |
Mortality and survival in active multiple myeloma | Take Quiz |
Minimal residual disease inside and outside bone marrow | Take Quiz |
Clinical manifestations in multiple myeloma | Take Quiz |
Imaging for detection of minimal residual disease in multiple myeloma | Take Quiz |
Gut activity and microbiome in multiple myeloma | Take Quiz |
Managing relapsed or refractory multiple myeloma | Take Quiz |
Vaccine effectiveness for pneumonia prevention in multiple myeloma | Take Quiz |
Minimal residual disease in multiple myeloma evaluation | Take Quiz |
Patient race and multiple myeloma risk | Take Quiz |
Multiple myeloma treatment | Take Quiz |
Progression and outcomes in multiple myeloma | Take Quiz |
Multiple myeloma-associated kidney disease | Take Quiz |
ASCO/CCO Guideline: Assessing multiple myeloma relapse | Take Quiz |
Whole-body imaging in multiple myeloma | Take Quiz |
Alcohol consumption and multiple myeloma | Take Quiz |
Prognosis in multiple myeloma | Take Quiz |
Bone and multiple myeloma | Take Quiz |
Complications of multiple myeloma | Take Quiz |
Clinical progression from MGUS to multiple myeloma | Take Quiz |
Diagnostic criteria for multiple myeloma | Take Quiz |
Pathogenesis of multiple myeloma | Take Quiz |
Multiple myeloma: Epidemiology & features | Take Quiz |
Myeloma survival: Post-transplant response and minimal residual disease | Take Quiz |
Multiple myeloma outcomes: Lower- & higher-volume facilities | Take Quiz |
Multiple myeloma: MRD and survival | Take Quiz |
Smoldering multiple myeloma in the United States | Take Quiz |
Prognosis of multiple myeloma | Take Quiz |
Plasma cell neoplasms: The basics | Take Quiz |
Treatment of multiple myeloma | Take Quiz |
Diagnosis and staging of multiple myeloma | Take Quiz |
CLL
CLL
Quiz | |
---|---|
CLL incidence by race and location | Take Quiz |
Antihistamine use for CLL cell death | Take Quiz |
COVID-19 in patients with CLL | Take Quiz |
Diagnosing CLL | Take Quiz |
CLL presentation | Take Quiz |
CLL etiology and epidemiology | Take Quiz |
CLL and minimal residual disease status | Take Quiz |
CLL, genetic aberrations, & the elderly | Take Quiz |
Molecular prognostic indicators in CLL | Take Quiz |
CLL management & prognosis | Take Quiz |
Diagnosis, classification, & prognostic factors of CLL | Take Quiz |
CLL: Risk factors & prognostic factors | Take Quiz |
Staging CLL | Take Quiz |
Treatment of CLL | Take Quiz |
Understanding CLL | Take Quiz |
CLL: Risk factors & epidemiology | Take Quiz |
Understanding familial CLL | Take Quiz |
Clinical manifestations of CLL | Take Quiz |
Diagnosis of CLL | Take Quiz |
Oncology
Oncology
Quiz | |
---|---|
CLL incidence by race and location | Take Quiz |
COVID-19 in patients with CLL | Take Quiz |
Diagnosing CLL | Take Quiz |
CLL presentation | Take Quiz |
ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
NSCLC: Delayed chemo & survival after surgery | Take Quiz |
ASCO Guidelines: Cancer treatment & cardiac dysfunction risk | Take Quiz |
PD-based cancer immunotherapy | Take Quiz |
Lung cancer: The role of imaging studies & chest CT | Take Quiz |
USPSTF Guidelines: Update on CRC screening | Take Quiz |
ASCO Guidelines: Management of renal cell masses | Take Quiz |
ASCO Guidelines: Integrating palliative care | Take Quiz |
ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
ASCO Guidelines: Cervical cancer screening | Take Quiz |
AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
Common RCC subtypes | Take Quiz |
AUA-SUO Guidelines: Diagnosis of non-muscle invasive bladder cancer | Take Quiz |
CLL management & prognosis | Take Quiz |
AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
CLL: Risk factors & prognostic factors | Take Quiz |
Treatment of CLL | Take Quiz |
CLL: Risk factors & epidemiology | Take Quiz |
Understanding familial CLL | Take Quiz |
Diagnosis of CLL | Take Quiz |
ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
Bowel preparation before colonoscopy | Take Quiz |
Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
Colonoscopy surveillance after screening & polypectomy | Take Quiz |
Endoscopy in the staging & management of CRC | Take Quiz |
Risk factors & prostate cancer | Take Quiz |
ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
CML
CML
Quiz | |
---|---|
Diagnostic findings in patients with CML | Take Quiz |
Management approaches in chronic myeloid leukemia | Take Quiz |
Initial clinical evaluation in CML diagnosis | Take Quiz |
Treating chronic myeloid leukemia | Take Quiz |
Laboratory testing in chronic myeloid leukemia diagnosis | Take Quiz |
Symptoms of early chronic myeloid leukemia | Take Quiz |
CML: TKI adherence | Take Quiz |
Pediatric Neuroblastoma
Pediatric Neuroblastoma
Quiz | |
---|---|
Managing pediatric neuroblastoma | Take Quiz |
Understanding pediatric neuroblastoma | Take Quiz |
Transfusion Medicine
Transfusion Medicine
Quiz | |
---|---|
Delayed hemolytic transfusion reactions | Take Quiz |
Acute hemolytic transfusion reactions | Take Quiz |
Platelet transfusion for GI bleeding in patients on antiplatelet agents | Take Quiz |
AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
Transfusion: Age of blood & mortality | Take Quiz |
Sickle Cell Disease
Sickle Cell Disease
Quiz | |
---|---|
Pathophysiology of sickle cell disease complications | Take Quiz |
Hyponatremia and acute painful episodes in sickle cell disease | Take Quiz |
Transfusion therapy for sickle cell disease | Take Quiz |
Features of sickle cell disease in adults | Take Quiz |
Acute chest syndrome in sickle cell disease | Take Quiz |
Chronic organ damage in sickle cell disease | Take Quiz |
Bleeding in sickle cell disease, Part 2 | Take Quiz |
Bleeding in sickle cell disease, Part 1 | Take Quiz |
ASH 2020 guidelines for sickle cell disease: Transfusion support, Part 2 | Take Quiz |
ASH 2020 Guidelines for sickle cell disease: Transfusion support, Part 1 | Take Quiz |
Guidelines: Cardiopulmonary and kidney disease in patients with sickle cell disease, Part 2 | Take Quiz |
Guidelines: Cardiopulmonary and kidney disease in patients with sickle cell disease, Part 1 | Take Quiz |
Common presentations and complications of sickle cell disease | Take Quiz |
Overview of sickle cell disease | Take Quiz |
Anemia
Anemia
Quiz | |
---|---|
Clinical features of warm autoimmune hemolytic anemia | Take Quiz |
Warm autoimmune hemolytic anemia diagnosis | Take Quiz |
Alpha thalassemia: Management | Take Quiz |
Types of alpha thalassemia | Take Quiz |
Alpha thalassemia: Physical findings & diagnosis | Take Quiz |
Drug-induced hemolysis: Pathophysiology, diagnosis, & treatment | Take Quiz |
Prognosis & management of megaloblastic anemia | Take Quiz |
Acute complications of sickle cell disease | Take Quiz |
Chronic complications of sickle cell disease | Take Quiz |
Anemia in adults | Take Quiz |
Hydroxyurea & transfusion therapy in sickle cell disease | Take Quiz |
Anemia in children | Take Quiz |
Diagnosis of anemia | Take Quiz |
Mechanisms of anemia | Take Quiz |
Drug-induced hemolysis: Clinical features | Take Quiz |
Diagnosis of megaloblastic anemia | Take Quiz |
Immunotherapy
Immunotherapy
Quiz | |
---|---|
Neuromuscular effects of immunotherapy | Take Quiz |
Cancer preventive & cancer treatment vaccines | Take Quiz |
Gene-expression profiling of tumors for immunotherapy | Take Quiz |
Non-specific cancer immunotherapies & adjuvants | Take Quiz |
Cancer cells & the immune system | Take Quiz |
Cancer treatment: Monoclonal antibodies | Take Quiz |
Forms of immunotherapy | Take Quiz |
Breast cancer: Emerging immunotherapy options | Take Quiz |
Immunotherapy & non-small cell lung cancer | Take Quiz |
Immune checkpoints & their inhibitors | Take Quiz |
Immune checkpoint inhibitors & tumors with mismatch repair deficiency | Take Quiz |
PD-based cancer immunotherapy | Take Quiz |
The role of TGF-beta in human cancer | Take Quiz |
Immune checkpoint blockade: Tumor interferon signaling | Take Quiz |
Efficacy of adoptive T-cell therapy | Take Quiz |
Targeting the necrosome for cancer therapy | Take Quiz |
Mechanisms involved in the tumor microenvironment | Take Quiz |
B-cell receptor CD4+ T cells in cancer immunotherapy | Take Quiz |
Improving T-cell potency via the CAR spacer | Take Quiz |
ROR gamma agonists & antitumor immunity | Take Quiz |
Role of B cell regulation in carcinogenesis | Take Quiz |
Cancer therapies: Vaccine adjuvants, Part 2 | Take Quiz |
Cancer therapies: Vaccine adjuvants, Part 1 | Take Quiz |
Validation of biomarkers to predict cancer immunotherapy response | Take Quiz |
Immune checkpoint modulators & immune cell therapy | Take Quiz |
Function of Hippo pathway kinases in cancer | Take Quiz |
Cancer immunotherapy: Immune checkpoint blockers | Take Quiz |
Cancer immunotherapy target: Wnt/β-catenin signaling in dendritic cells | Take Quiz |
Understanding oncolytic viruses | Take Quiz |
Cancer immunotherapy: Producer T cells – Part 2 | Take Quiz |
Cancer immunotherapy: Producer T cells – Part 1 | Take Quiz |
Cancer immunotherapy: Oncolytic viruses | Take Quiz |
Immune checkpoint blockade in cancer therapy | Take Quiz |
Cancer immunotherapy: Targeting microRNAs | Take Quiz |
Cancer immunotherapy: Role of Tcon & Treg | Take Quiz |
IL-24 in immunotherapy | Take Quiz |
Key omics modalities for precision oncology | Take Quiz |
CAR T cell therapy in cancer treatment | Take Quiz |
Categories of tumor antigens | Take Quiz |
Checkpoint blockade therapy: Immune monitoring assays | Take Quiz |
Principles of cancer immunotherapy | Take Quiz |
PD-1/PD-L1 immune checkpoint blockade therapy | Take Quiz |
Oncolytic viruses as immunotherapy | Take Quiz |
Approaches to cancer immunotherapy | Take Quiz |
Cancer immunotherapy mechanisms, advantages, & disadvantages | Take Quiz |
Immunotherapy in MIS CRC | Take Quiz |
Cancer immunotherapy: CAR design | Take Quiz |
Precision immunotherapy | Take Quiz |
Molecular mechanisms of immune avoidance | Take Quiz |
Immunotherapy for brain tumors | Take Quiz |
Adenosine in the tumor microenvironment | Take Quiz |
The role of TILs and MILs in cancer therapy | Take Quiz |
Leveraging the antigenic identity of tumors | Take Quiz |
Advances in cancer immunotherapy | Take Quiz |
Novel technologies for cancer immunotherapy | Take Quiz |
Understanding cancer immunology & immunotherapy | Take Quiz |
Personalized cancer immunotherapy: Novel immune monitoring | Take Quiz |
Understanding cancer immunotherapy | Take Quiz |
ASH 2019
ASH 2019
Quiz | |
---|---|
Risk of venous thromboembolism post-surgery | Take Quiz |
Patient age and chronic lymphocytic leukemia outcomes | Take Quiz |
Comorbidities and mortality in elderly patients with chronic lymphocytic leukemia | Take Quiz |
Thrombosis prevention and bleeding risk in anticoagulant combination therapy | Take Quiz |
Intracranial hemorrhage and immune thrombocytopenia inpatients | Take Quiz |
Clinical Guideline: Preventing VTE in surgical patients | Take Quiz |
Metastatic Breast Cancer
Metastatic Breast Cancer
Quiz | |
---|---|
Life-years impact of metastatic breast cancer among US women | Take Quiz |
De novo metastatic breast cancer: Occurrence & outcome by subtype | Take Quiz |
Metastatic breast cancer: Adapting to changes during treatment | Take Quiz |
Metastatic breast cancer with ESR1 mutation: Clinical management considerations | Take Quiz |
ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
Lymphoma & Plasma Cell Disorders
Lymphoma & Plasma Cell Disorders
Quiz | |
---|---|
Overview of BIA-ALCL | Take Quiz |
Treatment of adult HL | Take Quiz |
Diagnosis & pathogenesis of primary CNS lymphoma | Take Quiz |
Indolent & aggressive NHL | Take Quiz |
Cellular classification & treatment of NHL | Take Quiz |
Understanding NHL | Take Quiz |
Prognosis of primary CNS lymphoma | Take Quiz |
Gastroenterology
Gastroenterology
Quiz | |
---|---|
Post-surgical survival factors in pancreatic cancer | Take Quiz |
Diet and hepatocellular carcinoma risk | Take Quiz |
Precancerous colorectal neoplasms and race | Take Quiz |
HCC: Prognosis, diagnostic imaging & liver biopsy | Take Quiz |
Neuroendocrine tumors: Diagnosis | Take Quiz |
Pancreatic neuroendocrine tumors: Pathogenesis & prognostic factors | Take Quiz |
Colorectal cancer & endoscopic resection | Take Quiz |
USPSTF Guidelines: Update on CRC screening | Take Quiz |
Pathophysiology & prognosis of PDA | Take Quiz |
Staging, radiographic, & laboratory evaluation of PDA | Take Quiz |
Bowel preparation before colonoscopy | Take Quiz |
Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
Colonoscopy surveillance after screening & polypectomy | Take Quiz |
Endoscopy in the staging & management of CRC | Take Quiz |
Thrombosis
Thrombosis
Quiz | |
---|---|
Guideline Update: Preventing venous thromboembolism in medical inpatients | Take Quiz |
Characteristics of essential thrombocythemia | Take Quiz |
Pathogenesis of immune thrombocytopenia | Take Quiz |
Hypercoagulable states: Clinical features | Take Quiz |
ASH Guidelines: Subsequent management of ITP | Take Quiz |
ASH Guidelines: Initial management of immune thrombocytopenia | Take Quiz |
ASH Guidelines: Typical features & diagnosis of immune thrombocytopenia | Take Quiz |
Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
Guideline: Antithrombotic therapy for VTE, Part 1 | Take Quiz |
Sarcoma & GIST
Sarcoma & GIST
Quiz | |
---|---|
Managing alveolar soft-part sarcoma | Take Quiz |
Sarcoma: Importance of histology | Take Quiz |
Sarcoma imaging: STS or benign processes? | Take Quiz |
High-risk sarcomas & chemoradiation | Take Quiz |
Sarcoma: Radiotherapy benefits | Take Quiz |
Sarcoma: Radiation and surgical options | Take Quiz |
Stages of sarcoma | Take Quiz |
Diagnosing sarcoma | Take Quiz |
Sarcoma: Disease overview | Take Quiz |
HIV
HIV
Quiz | |
---|---|
HIV: Diarrheal alimentary tract disease, Part 1 | Take Quiz |
CNS/Brain Cancer
CNS/Brain Cancer
Quiz | |
---|---|
Glioblastoma | Take Quiz |
Indolent Lymphoma
Indolent Lymphoma
Quiz | |
---|---|
Mycosis fungoides: Early stages & treatment | Take Quiz |
Nodal marginal zone lymphoma: Epidemiology & clinical presentation | Take Quiz |
Splenic marginal zone lymphoma: Features, diagnosis, & management | Take Quiz |
Indolent B-cell lymphoma: Autologous & allogeneic stem cell transplantation | Take Quiz |
Waldenström’s macroglobulinemia & stem cell transplantation | Take Quiz |
Characteristics across indolent NHL subtypes | Take Quiz |
Mycosis fungoides: Clinical presentation, prognosis, & survival | Take Quiz |
A subset of indolent lymphomas: Features & outcomes | Take Quiz |
Mass cytometry study of follicular lymphoma tumors reveals cellular characteristics | Take Quiz |
Cutaneous B-cell lymphoma: Epidemiology & diagnosis | Take Quiz |
Marginal zone lymphoma & primary cutaneous anaplastic large cell lymphoma | Take Quiz |
Indolent lymphoma subtypes: Marginal zone lymphoma | Take Quiz |
Indolent lymphoma subtypes: Lymphoplasmacytic lymphoma | Take Quiz |
Indolent lymphoma subtypes: Follicular lymphoma | Take Quiz |
Waldenström macroglobulinemia: Symptoms & criteria for treatment | Take Quiz |
Clinical Guidelines
Clinical Guidelines
Quiz | |
---|---|
ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
ASCO Guidelines: Cancer treatment & cardiac dysfunction risk | Take Quiz |
Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
ASCO Guidelines: Management of renal cell masses | Take Quiz |
ATA Guidelines: Intraoperative voice and parathyroid management & follow-up in patients with DTC | Take Quiz |
ATA Guidelines: Voice and parathyroid issues in DTC | Take Quiz |
ASCO Guidelines: Integrating palliative care | Take Quiz |
ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
ASCO Guidelines: Cervical cancer screening | Take Quiz |
ASBMT Guidelines: Autologous progenitor cell transplant | Take Quiz |
AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
ASBMT Guidelines: Autologous & allogeneic HCT considerations in special populations & comorbidities | Take Quiz |
AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
ASBMT Guidelines: Allogeneic progenitor cell transplant | Take Quiz |
Common RCC subtypes | Take Quiz |
AUA-SUO Guidelines: Diagnosis of non-muscle invasive bladder cancer | Take Quiz |
AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
NHF Guideline: Hemophilia care models | Take Quiz |
Acute complications of sickle cell disease | Take Quiz |
Chronic complications of sickle cell disease | Take Quiz |
Hydroxyurea & transfusion therapy in sickle cell disease | Take Quiz |
ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
Bowel preparation before colonoscopy | Take Quiz |
Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
Colonoscopy surveillance after screening & polypectomy | Take Quiz |
Endoscopy in the staging & management of CRC | Take Quiz |
Risk factors & prostate cancer | Take Quiz |
ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
Nonmelanoma Skin Cancer
Nonmelanoma Skin Cancer
Quiz | |
---|---|
First FDA-approved Merkel cell carcinoma treatment | Take Quiz |
Patient & Survivor Care
Patient & Survivor Care
Quiz | |
---|---|
HCT & non-HCT cancer survivors: Morbidity & mortality | Take Quiz |
ASCO Guidelines: Integrating palliative care | Take Quiz |
Cancer survivors: Medication use for anxiety & depression | Take Quiz |
Myelodysplastic Syndrome
Myelodysplastic Syndrome
Quiz | |
---|---|
Clonal hematopoiesis & risk for therapy-related cancer | Take Quiz |
Myelodysplastic syndrome: Genetic mutations & outcomes | Take Quiz |
Chronic myelomonocytic leukemia: Survival after transplant | Take Quiz |
Cellular Therapy
Cellular Therapy
Quiz | |
---|---|
Prognostic value of hematopoietic cell transplant comorbidity index | Take Quiz |
Myelodysplastic syndrome: Genetic mutations & outcomes | Take Quiz |
HSC donors & health-related quality of life | Take Quiz |
HSCT outcomes & vancomycin-resistant enterococcus colonization & bacteremia | Take Quiz |
Double-hit lymphomas: Outcomes after ASCT | Take Quiz |
ALL
ALL
Quiz | |
---|---|
Guidelines: Diagnostic workup of acute leukemia | Take Quiz |
NCHS Report: Pediatric cancer rates | Take Quiz |
Ph-like ALL in adults | Take Quiz |
Acute leukemia: Epidemiology & pathophysiology | Take Quiz |
Clinical signs & symptoms of acute leukemia | Take Quiz |
Initial management & tumor lysis syndrome in acute leukemia | Take Quiz |
Hematology
Hematology
Quiz | |
---|---|
Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
ASBMT Guidelines: Autologous progenitor cell transplant | Take Quiz |
AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
ASBMT Guidelines: Autologous & allogeneic HCT considerations in special populations & comorbidities | Take Quiz |
ASBMT Guidelines: Allogeneic progenitor cell transplant | Take Quiz |
NHF Guideline: Hemophilia care models | Take Quiz |
Aggressive Lymphomas
Aggressive Lymphomas
Quiz | |
---|---|
Double-hit lymphomas: Outcomes after ASCT | Take Quiz |
HCV: Increased non-Hodgkin lymphoma risk? | Take Quiz |
Non-Hodgkin lymphoma risk & HIV-Hepatitis coinfection | Take Quiz |
Case-Based Quizzes
Case-Based Quizzes
Quiz | |
---|---|
Advanced & previously treated NSCLC: The OAK & POPLAR trials by Bobby Daly, MD, MBA | Take Quiz |
PD-L1-Positive NSCLC and KEYNOTE-024, by Bobby Daly, MD, MBA | Take Quiz |
Mantle Cell Lymphoma
Mantle Cell Lymphoma
Quiz | |
---|---|
MCL: Epidemiology, subtypes, & diagnosis | Take Quiz |
MCL: Diagnosis, treatment, & prognosis | Take Quiz |
Leukemia, Myelodysplasia, Transplantation
Leukemia, Myelodysplasia, Transplantation
Quiz | |
---|---|
Testing & mutational analysis in chronic myeloid leukemia | Take Quiz |